<SEC-DOCUMENT>0001493152-21-005114-index.html : 20210301
<SEC-HEADER>0001493152-21-005114.hdr.sgml : 20210301
<ACCEPTANCE-DATETIME>20210301164249
ACCESSION NUMBER:		0001493152-21-005114
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210226
FILED AS OF DATE:		20210301
DATE AS OF CHANGE:		20210301

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Jemapete Christopher J
		CENTRAL INDEX KEY:			0001741021

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33635
		FILM NUMBER:		21698616

	MAIL ADDRESS:	
		STREET 1:		6888 SOUTH IRVINGTON COURT
		CITY:			AURORA
		STATE:			CO
		ZIP:			80016

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gene Biotherapeutics, Inc.
		CENTRAL INDEX KEY:			0000772320
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				840635673
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		11750 SORRENTO VALLEY ROAD
		STREET 2:		SUITE 250
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		(858) 436-1000

	MAIL ADDRESS:	
		STREET 1:		11750 SORRENTO VALLEY ROAD
		STREET 2:		SUITE 250
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Taxus Cardium Pharmaceuticals Group Inc.
		DATE OF NAME CHANGE:	20140318

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cardium Therapeutics, Inc.
		DATE OF NAME CHANGE:	20060118

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cadium Therapeutics, Inc.
		DATE OF NAME CHANGE:	20060118
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
</SEC-DOCUMENT>